Crunching the numbers for FNCHQ... Refresh in a moment for the full analysis.
Finch Therapeutics Group, Inc. (FNCHQ)
Healthcare
weak
$8.0
Updated: 2026-04-13
39
TradeApes Score
reduce
Financial Strength
50
Mixed
Operating Trend
20
Stressed
Valuation
40
Weak
Capital Allocation
45
Mixed
Risk
50
Mixed
Key Findings
+
Active buybacks — share count declining, capital returned to owners
−
Sharp revenue decline — sales down more than 15% year over year
3 free score cards remaining
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor.
The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.